SiMologics is a Glasgow-based biotechnology company, established in 2018, and developing platform technologies to engineer better antibody-based biotherapeutics.

Our work is built around two complementary platforms:
SmartLinker™: a precision linker and conjugation technology designed to connect antibodies with nanoparticles and other payloads for therapeutic and diagnostic applications.
SmartAntibody™: an AI-enabled antibody platform supporting antibody sequence analysis, design, humanisation, optimisation, and candidate prioritisation.
By combining advanced antibody conjugation with computational antibody engineering, SiMologics aims to help accelerate antibody development, reduce experimental risk, and support the creation of higher-performing antibody-based products.

We are interested in collaborations with academic groups, biotech companies, CROs, translational researchers, funders, investors, and innovation partners working across antibody discovery, antibody engineering, bioconjugation, nanomedicine, diagnostics, and therapeutic development.

SiMologics

Org chart

Teams

Offices

SiMologics

Org chart

Teams

Offices

Related companies